Envoy Therapeutics, Inc.

📍 Jupiter, United States🗓 Founded 2008👥 1 employees💰 Last funded May 2010
Biotechnology Research🌐 envoytherapeutics.com
Website LinkedIn
Started with an initial $8 million financing in October 2009, Envoy Therapeutics used a proprietary technology called bacTRAP to identify target proteins expressed in the circuitry of neurological and psychiatric diseases and then discovered and optimized drug compounds that acted on those proteins. In November 2012, Takeda Pharmaceuticals purchased Envoy for $140 million.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Envoy Therapeutics, Inc.?
Envoy Therapeutics, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Envoy Therapeutics, Inc. last raise funding?
The most recent investment in Envoy Therapeutics, Inc. recorded on gritt.io was in May 2010.
When was Envoy Therapeutics, Inc. founded?
Envoy Therapeutics, Inc. was founded in 2008.
What industry is Envoy Therapeutics, Inc. in?
Envoy Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Envoy Therapeutics, Inc. based?
Envoy Therapeutics, Inc. is headquartered in Jupiter, United States.